healthcare

Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity marketFinance

Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market

Image for Novo Nordisk shares rebound as FDA targets illegal drug copiesFinance

Novo Nordisk shares rebound as FDA targets illegal drug copies

Image for Danone recalls more baby formula in Europe after EU sets toxin thresholdFinance

Danone recalls more baby formula in Europe after EU sets toxin threshold

Image for Novo Nordisk CEO says Hims $49 compounded Wegovy pill a 'waste' of moneyFinance

Novo Nordisk CEO says Hims $49 compounded Wegovy pill a 'waste' of money

Image for Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding

Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding

Date: February 5, 2026

COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online telehealth company said it will begin offering compounded copies of the...

Image for Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly

Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly

Date: February 5, 2026

NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health will begin offering copies of Novo Nordisk's new Wegovy pill at an introductory price of $49 per month, the company said...

Image for Analysis-Novo Nordisk risks weight-loss price war as discount pressures deepen

Analysis-Novo Nordisk risks weight-loss price war as discount pressures deepen

Date: February 4, 2026

By Maggie Fick, Jacob Gronholt-Pedersen and Bhanvi Satija LONDON, Feb 4 (Reuters) - Danish obesity drug maker Novo Nordisk's new CEO risks being on the losing side of a damaging price war as "...

Image for European stocks close at record high even as tech, healthcare drag

European stocks close at record high even as tech, healthcare drag

Date: February 4, 2026

Feb 4 (Reuters) - European shares were muted on Wednesday as losses in Novo Nordisk offset strength in energy stocks, with investors also tracking software shares and awaiting a key inflation report....

Image for Novo Nordisk sees 'painful' US price cuts for Wegovy as investment in  the future

Novo Nordisk sees 'painful' US price cuts for Wegovy as investment in  the future

Date: February 4, 2026

COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk CEO Mike Doustdar said on Wednesday that the price reductions for its obesity drug Wegovy in the U.S. are "painful" for the company's financial results but...

Image for Spain performs pioneering face transplant from donor who requested assisted dying

Spain performs pioneering face transplant from donor who requested assisted dying

Date: February 2, 2026

MADRID, Feb 2 (Reuters) - A hospital in Barcelona said on Monday it had performed a pioneering facial transplant in which the donor, in a world first, had offered her face for donation before...